FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 04:25:40 2024-07-04 EDT | ||
| 0.54 EUR | +17.90% |
|
| Current month | -21.71% | ||
| 1 month | -22.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 0.54 | +17.90% |
| 24-07-03 | 0.458 | -17.63% |
| 24-07-02 | 0.556 | -1.42% |
| 24-07-01 | 0.564 | -3.59% |
| 24-06-28 | 0.585 | +0.52% |
Real-time BOERSE MUENCHEN
Last update July 04, 2024 at 04:25 am
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ96KP |
| ISIN | DE000GZ96KP4 |
| Date issued | 2023-02-23 |
| Strike | 286.9 $ |
| Maturity | Unlimited |
| Parity | 41.84 : 1 |
| Emission price | 8.83 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.25 € |
|---|---|
| Lowest since issue | 0.227 € |
| Spread | 0.02 € |
| Spread % | 4.08% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
